Form 8-K - Current report:
SEC Accession No. 0001193125-24-177726
Filing Date
2024-07-11
Accepted
2024-07-11 16:12:29
Documents
18
Period of Report
2024-07-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d807091d8k.htm   iXBRL 8-K 30592
2 EX-1.1 d807091dex11.htm EX-1.1 277708
3 EX-4.1 d807091dex41.htm EX-4.1 64438
4 EX-5.1 d807091dex51.htm EX-5.1 18116
8 GRAPHIC g807091g0711061605164.jpg GRAPHIC 2864
9 GRAPHIC g807091g0711061605645.jpg GRAPHIC 1674
  Complete submission text file 0001193125-24-177726.txt   622387

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idya-20240709.xsd EX-101.SCH 2857
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20240709_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20240709_pre.xml EX-101.PRE 11266
20 EXTRACTED XBRL INSTANCE DOCUMENT d807091d8k_htm.xml XML 3652
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 241112183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)